| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MORPHINE SULFATE | 3 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MORPHINE SULFATE | 2 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | 65f87900-8d23-4fb3-be44-1d116aedac78 | 4 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Drug Facts | 13 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | These highlights do not include all the information needed to use oxcarbazepine oral suspension, USP safely and effectively. See full prescribing information for oxcarbazepine oral suspension, USP. Oxcarbazepine oral suspension, USP for oral administration Initial U.S. Approval: 2000 | 8 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Drug Facts | 3 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Citalopram Tablets, USP 10 mg, 20 mg, and 40 mg Rx Only | 1 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Libera Tos Children | 2 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Libera Tos Diabetic | 2 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Nifedipine Extended-Release Tablets, USP 30 mg | 2 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | df0af55f-f2af-4786-bbb3-5bc59570b3f2 | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Antiseptic Skin Cleanser (Chlorhexidine Gluconate 2% Topical Solution, USP) | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MORPHINE SULFATE ER - C-II 15 mg TABLETS | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Drug Fact | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Drug Fact | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Drug Fact | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Drug Fact | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Drug Fact | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Drug Fact | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Personal Care Oil Free Foaming Facial Cleanser | 3 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Morphine Sulfate Extended-Release Tablets CII 15 mg 30 mg 60 mg 100 mg* 200 mg* | 2 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | 70a304d9-755b-40a2-a48e-491c8355410c | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | 3a7caf9f-2552-41be-a7d4-ac3a18b5a0d5 | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | TobraDex | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | 6ce1d9b9-3a71-4c10-9c09-6259088baafb | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MS CONTINĀ® (morphine sulfate controlled-release) Tablets CII 15 mg 30 mg 60 mg 100 mg * 200 mg * | 1 | |
| Hydroxyethyl Cellulose (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Drug Facts | 3 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | Glipizide Extended-Release Tablets Rx only | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | 83d5ef4b-8b46-48b6-ae5a-9a0e493350a0 | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | a6c39757-4551-4493-b27f-5b311fd1fc77 | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | QuikSpray Advanced Hand Sanitizing Spray | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | QuikSpray Advanced Hand Sanitizing Spray | 1 | |
| hydroxyethyl cellulose (140 CPS at 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MS CONTIN (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 2084 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | FORMALDEHYDE SOLUTION [ROCHESTER PHARMACEUTICALS] | 20 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | IPRATROPIUM BROMIDE SPRAY [ROXANE LABORATORIES, INC] | 9 | |
| hydroxyethyl cellulose (140 MPA.S at 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MS CONTIN (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [PURDUE PHARMA LP] | 9 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | IPRATROPIUM BROMIDE SPRAY [ROXANE LABORATORIES, INC] | 7 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | JAFRA PRO (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) KIT [JAFRA COSMETICS INTERNATIONAL INC] | 7 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [RHODES PHARMACEUTICALS L. P.] | 7 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 7 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 7 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | CITALOPRAM (CITALOPRAM ) TABLET, FILM COATED CITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [APOTEX CORP.] | 6 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | DICLOFENAC SODIUM TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 6 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | FLUVOXAMINE MALEATE TABLET [APOTEX CORP] | 6 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [AMERICAN HEALTH PACKAGING] | 6 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | KLENSKIN KIDS SHOWERON SUNSCREEN SPF-30 (AVOBENZONE, OCTOCRYLENE, OCTINOXATE) GEL [COLABS INTL. CORP] | 5 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | TRAMADOL HYDROCHLORIDE TABLET, COATED [APOTEX CORP.] | 5 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | BIOTENE (SODIUM MONOFLUOROPHOSPHATE) PASTE BIOTENE FRESH MINT ORIGINAL (SODIUM MONOFLUOROPHOSPHATE) PASTE BIOTENE GENTLE MINT (SODIUM MONOFLUOROPHOSPHATE) GEL [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP] | 4 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | FENTANYL PATCH [PAR PHARMACEUTICAL INC.] | 4 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) SOLUTION [APOTEX CORP] | 4 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | BELBUCA (BUPRENORPHINE HYDROCHLORIDE) FILM [ENDO PHARMACEUTICALS] | 3 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | CARVEDILOL TABLET, FILM COATED [APOTEX CORP.] | 3 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | HYDROQUINONE WITH SUNSCREENS (HYDROQUINONE, DIOXYBENZONE, OXYBENZONE, PADIMATE O) CREAM [PREFERRED PHARMACEUTICALS, INC] | 3 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 3 | |
| Hydroxyethyl Cellulose (140 MPA.S at 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | PREDNISOLONE SODIUM PHOSPHATE SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 3 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | PRO-DEN RX (SODIUM FLUORIDE) GEL [ZILA THERAPEUTICS, INC.] | 3 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | REZAMID (SULFUR AND RESORCINOL) LOTION [SUMMERS LABORATORIES INC] | 3 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | TERPENICOL ANTIFUNGAL (UNDECYLENIC ACID) LIQUID [BLAINE LABS INC.] | 3 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | ACLARO HYDROQUINONE (HYDROQUINONE ) EMULSION [INNOCUTIS] | 2 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | DICLOFENAC SODIUM GEL [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.] | 2 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | DYNA-HEX 75 (ANTISEPTIC HANDWASH) SOLUTION [BAJAJ MEDICAL, LLC] | 2 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | GUAIFENESIN SOLUTION [PHARMACEUTICAL ASSOCIATES, INC.] | 2 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 2 | |
| hydroxyethyl cellulose (140 mpa.s at 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | NIFEDIPINE TABLET, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA] | 2 | |
| hydroxyethyl cellulose (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | NIFEDIPINE TABLET, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA] | 2 | |
| hydroxyethyl cellulose (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | NIFEDIPINE TABLET, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA] | 2 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.] | 2 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | PREDNISOLONE SODIUM PHOSPHATE SOLUTION [UNIT DOSE SERVICES] | 2 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | PRO-DEN RX (STANNOUS FLUORIDE) GEL [ZILA THERAPEUTICS, INC.] | 2 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | UMECTA UREA (UREA ) FILM [INNOCUTIS HOLDINGS LLC] | 2 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | APLICARE ANTISEPTIC CHLORHEXIDINE GLUCONATE (CHLORHEXIDINE GLUCONATE) SOLUTION [APLICARE, INC.] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | APLICARE ANTISEPTIC CHLORHEXIDINE GLUCONATE (CHLORHEXIDINE GLUCONATE) SOLUTION [APLICARE, INC.] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | CHLORHEXIDINE SCRUB (CHLORHEXIDINE GLUCONATE) SOLUTION [AMERICAN ANIMAL HEALTH, INC.] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | CITALOPRAM HYDROBROMIDE TABLET [REMEDYREPACK INC. ] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | CITALOPRAM HYDROBROMIDE TABLET, FILM COATED [CARDINAL HEALTH] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | ELTA DERMAVASE (ZINC OXIDE) CREAM [SWISS-AMERICAN PRODUCTS] | 1 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | INACTIVE INGREDIENT | 8136Y38GY5 | EXTRASHADE DAILY DEFENSE HYDRATING SUNSCREEN SPF 30 (AVOBENZONE, OCTINOXATE, OCTISALATE, OXYBENZONE) LOTION [EXTRASHADE A SUB OF VERSITILE GROUP] | 1 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | FLUVOXAMINE MALEATE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | FLUVOXAMINE MALEATE TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | GLIPIZIDE ER (GLIPIZIDE) TABLET, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | IPRATROPIUM BROMIDE SPRAY [REMEDYREPACK INC. ] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | IPRATROPIUM BROMIDE SPRAY [REMEDYREPACK INC. ] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MS CONTIN (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | OIL-FREE DAILY HYDRATION SPF 15 (OCTINOXATE, AVOBENZONE) CREAM [BOSCIA LLC] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH] | 1 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [MCKESSON CONTRACT PACKAGING] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | PENTOXIFYLLINE TABLET, FILM COATED, EXTENDED RELEASE [REMEDYREPACK INC. ] | 1 | |
| Hydroxyethyl Cellulose (140 MPA.S at 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | PREDNISOLONE SODIUM PHOSPHATE SOLUTION [PROFICIENT RX LP] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | PRO-DEN RX (SODIUM FLUORIDE) GEL [ZILA THERAPEUTICS, INC.] | 1 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | SF (1.1% SODIUM FLUORIDE) GEL [CYPRESS PHARMACEUTICAL, INC.] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | TINAACIDE ATHLETES FOOT (UNDECYLENIC ACID) CREAM [BLAINE LABS INC.] | 1 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | TINEACIDE ANTIFUNGAL (MICONAZOLE NITRATE) CREAM [BLAINE LABS INC.] | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | TINEACIDE PHYSICIAN FORMULA (UNDECYLENIC ACID) CREAM TINEACIDE (UNDECYLENIC ACID) CREAM [BLAINE LABS INC.] | 1 | |
| hydroxyethyl cellulose (140 mpa.s at 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | TYLENOL 8 HR ARTHRITIS PAIN (ACETAMINOPHEN) TABLET, EXTENDED RELEASE [MCNEIL CONSUMER HEALTHCARE DIV OF MCNEIL PPC, INC.] | 1 | |